Innovation Pass Pilot Launched

An pilot scheme for the 'Innovation Pass', which would allow earlier access to innovative medicines targeting rare diseases that have not been appraised by the National Institute for Health and Clinical Excellence (NICE), has been launched by the UK government. As the number of patients using these drugs is small, the current lack of available evidence means that NICE is not able to conduct a full assessment for their use on the National Health Service (NHS). Drugs issued with a pass during the three-year pilot of the scheme will be licensed and given to patients, with

To read the full article, please choose one of the following options: